Dapsone RxDapsone for skin

Dapsone Rx / Comparisons

Dapsone rx vs clindamycin for acne: which one wins?

Last updated 2026-07-27

TL;DR

For inflammatory acne, topical dapsone (Aczone 5%/7.5%) and clindamycin (often paired with benzoyl peroxide) perform similarly, though dapsone shows a notable edge in adult women with hormonal-pattern acne. Clindamycin alone risks bacterial resistance and is rarely prescribed solo anymore. Oral dapsone is a different drug entirely, an antibiotic that needs G6PD blood testing before use.

What's the actual difference between dapsone and clindamycin for acne?

Dapsone (brand name Aczone, available as 5% and 7.5% gel) and clindamycin are both topical acne treatments, but they work through different mechanisms and come with different baggage. Dapsone is a sulfone with anti-inflammatory properties; it calms the inflamed, red bumps of acne without functioning primarily as an antibiotic when applied to skin. Clindamycin is a true antibiotic (a lincosamide) that kills Cutibacterium acnes bacteria on the skin surface. That mechanism difference matters for two practical reasons. First, dapsone doesn't drive antibiotic resistance the way topical clindamycin can, which is why dermatology guidelines now say clindamycin should almost never be used alone [1]. Second, dapsone's anti-inflammatory action makes it a reasonable pick for the kind of deep, tender, hormonal-pattern acne that responds poorly to plain antibacterial approaches. Both are FDA-approved topical acne treatments. Both are generally considered low-risk when used on skin. The topical story is the one most people searching this comparison actually want; the oral dapsone story (an antibiotic with real hematologic risks) is a completely separate conversation covered further down.

How do the actual clinical trial results compare?

Trial duration12 weeks [3]10-12 weeks [2]
Inflammatory lesion reduction~48-49%~50-60%
Vehicle/control reduction~43%Varies by study
Resistance riskLowHigher if used alone [1]
FDA approval basisTwo phase 3 RCTs [3]Multiple RCTs, combo products [2]

The main trials for topical dapsone gel 5% were two identical 12-week, randomized, vehicle-controlled studies with over 3,000 combined participants, published in the Journal of Drugs in Dermatology. Success rates (global acne severity rated 'none' or 'minimal') landed around 42-48% for dapsone versus roughly 35% for vehicle gel alone [2]. For dapsone 7.5% gel (the once-daily formulation), the phase 3 trials showed treatment success in about 28-30% of patients at week 12 compared to around 20% with vehicle, with inflammatory lesion counts dropping by roughly 48-49% versus about 43% for vehicle [3]. Clindamycin's trial data is older and mostly comes from combination studies. Clindamycin 1%/benzoyl peroxide 5% gel trials generally show inflammatory lesion reductions in the 50-60% range over 10-12 weeks, often outperforming either ingredient alone [2]. Head-to-head trials directly pitting dapsone against clindamycin monotherapy are limited. Most of what dermatologists rely on is indirect comparison across separate vehicle-controlled trials, which is an honest limitation worth naming rather than glossing over. | Measure | Dapsone gel 7.5% | Clindamycin 1%/BPO 5% |

Does dapsone work better for women with hormonal acne?

There's a specific subgroup finding worth knowing about: post-hoc analysis of the dapsone gel 5% trials found adult women (over age 25) showed a stronger treatment response than the overall study population, an effect that got enough attention that some dermatologists now specifically favor dapsone for adult female acne along the jawline and chin [2]. This isn't a formal FDA-labeled indication for that subgroup; it's a secondary analysis. But it lines up with clinical experience: the jaw-and-chin, cyclical, inflammatory pattern common in adult women tends to be more inflammatory than bacterial in nature, which is exactly the profile dapsone's anti-inflammatory mechanism is suited for. Clindamycin doesn't have a similar sex-specific signal in its literature. It works on the bacterial and comedonal side of acne broadly, without a documented edge in any age or sex subgroup that I'm aware of.

12-week inflammatory lesion reduction: topical dapsone vs clindamycin/BPO Percent reduction in inflammatory lesion counts from baseline, phase 3 trial data 48.5% Dapsone gel 7.5% 43% Dapsone vehicle… 55% Clindamycin/BPO… 45% Topical antibio… Source: FDA prescribing information, Aczone 7.5% and clindamycin/benzoyl peroxide gel

Which one has worse side effects?

Topical dapsone's most common side effects are mild: dryness, redness, and peeling at the application site, plus a well-known cosmetic quirk. Applying dapsone gel at the same time as benzoyl peroxide products can cause temporary yellow-orange skin discoloration, which is harmless but startling if you don't expect it [4]. Dermatologists generally recommend applying them at different times of day to avoid this. Topical clindamycin's side effects are similarly mild on skin (dryness, irritation), but its real downside shows up over time: because it's a genuine antibiotic, using it alone for months can select for resistant C. acnes strains, undermining its own effectiveness and potentially cross-resistance with other antibiotics used for unrelated infections [1]. That's the core reason the American Academy of Dermatology's acne guideline states topical antibiotics should be used in combination with benzoyl peroxide and for limited durations, not as long-term monotherapy [1]. Neither topical drug carries the serious risks associated with oral dapsone, which is a different medication class entirely and covered in its own section below.

Can you use dapsone and clindamycin together?

Yes, dermatologists do combine them, particularly for moderate inflammatory acne that isn't responding to one agent alone. Dapsone's anti-inflammatory action and clindamycin's antibacterial action target different parts of acne's pathophysiology, so combining them is mechanistically sensible. The practical wrinkle is timing and layering. Clindamycin combined with benzoyl peroxide is common (often as a single combination product), and dapsone can be layered on top or used at a separate time of day. The main reason to separate application times isn't a drug interaction risk, it's the orange-discoloration issue mentioned above when dapsone meets benzoyl peroxide directly on skin [4]. If you're building a routine that includes multiple actives, get it reviewed by a prescriber rather than guessing at layering order. A dapsone dosage calculator can help you understand application frequency, but combination regimens are individualized enough that a provider should sign off on the specific pairing.

What is oral dapsone and why is it a completely different risk category?

This is the part of the comparison that gets dangerously flattened online, so it deserves its own clear section. Oral dapsone is a sulfone antibiotic used for conditions like dermatitis herpetiformis, leprosy (Hansen's disease), and certain other dermatologic and infectious conditions. It is not an acne treatment and is not what most people mean when they search 'dapsone for acne'. Oral dapsone carries serious, well-documented risks that topical dapsone does not. The FDA label for oral dapsone lists hemolysis and hemolytic anemia, methemoglobinemia, agranulocytosis, peripheral neuropathy, and a severe, sometimes fatal reaction called dapsone hypersensitivity syndrome (also called sulfone syndrome), which can involve fever, rash, and organ involvement typically appearing 2 to 6 weeks after starting the drug [5]. The single most important safety step before anyone starts oral dapsone is G6PD (glucose-6-phosphate dehydrogenase) deficiency testing. People with G6PD deficiency, an inherited enzyme condition more common in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent, are at sharply elevated risk of severe hemolytic anemia on this drug. The FDA label explicitly states that patients should be screened for G6PD deficiency before initiating dapsone therapy, and that hemolysis is dose-related and expected to some degree even in patients with normal G6PD levels [5]. The CDC's guidance on G6PD deficiency confirms it's one of the most common enzyme deficiencies worldwide, affecting an estimated 400 million people globally, with materially higher prevalence in specific populations . That's not a rare edge case to shrug off; it's a standard pre-treatment screening step precisely because the consequence of skipping it can be severe.

Does topical dapsone carry the same G6PD risk as oral dapsone?

No, and this distinction is the single most important thing to understand in this whole comparison. Topical dapsone gel is absorbed into the bloodstream at levels far lower than oral dosing, and clinical trials of Aczone did not require G6PD screening before use. The prescribing information for topical dapsone gel notes that hematologic effects (like the hemolysis seen with oral dapsone) were not observed at rates different from vehicle in clinical trials, even in patients with G6PD deficiency who were included in some study populations [4]. That's meaningfully different from oral dapsone, where G6PD screening is a standard-of-care prerequisite [5]. So if you're using Aczone gel on your face for acne, you are not in the same risk category as someone taking oral dapsone tablets for dermatitis herpetiformis or leprosy. Conflating the two is the most common and most dangerous mistake people make when researching this drug online. If your dermatologist or prescriber ever suggests oral dapsone for a skin condition, ask directly whether G6PD testing has been done, because it should have been.

How do the costs compare?

Generic topical clindamycin is inexpensive, commonly running somewhere in the range of $10-30 per tube with a GoodRx-type discount, since it's been off patent for decades and is widely stocked. Combination clindamycin/benzoyl peroxide products cost more, depending on brand and insurance coverage. Topical dapsone (Aczone) has generic versions available now, which has brought its price down substantially from brand-only pricing, but it still tends to run higher than plain generic clindamycin at most pharmacies. Exact prices vary widely by pharmacy, insurance formulary, and location, so the honest answer is to check current pricing at your own pharmacy or through a prescription discount tool rather than trust a fixed number here, since these prices shift often. Insurance coverage also varies: some plans put Aczone on a higher tier or require step therapy through a generic option first. If cost is your deciding factor, ask your prescriber about generic dapsone gel specifically, and compare it against clindamycin/BPO combination pricing at your usual pharmacy before assuming one is definitively cheaper.

How long does it take each one to work?

Neither works fast, and this is worth setting expectations on early so people don't quit at week three. In the dapsone 7.5% gel trials, meaningful separation from vehicle in lesion counts was measured at week 12, the standard trial endpoint for acne studies [3]. Most dermatologists tell patients to expect visible improvement starting around 8-12 weeks of consistent daily use. Clindamycin/benzoyl peroxide combination trials follow a similar timeline, with lesion count improvements typically assessed at 10-12 weeks [2]. Some people notice modest improvement earlier, by weeks 4-6, but full effect takes the full 12-week course. The practical implication: don't switch products every few weeks out of impatience. Acne treatments, dapsone and clindamycin included, need roughly a three-month trial to fairly judge whether they're working. If you're not seeing improvement by then, that's the right time to talk to a prescriber about switching or combining agents, not before.

Which one is right for you: a quick decision guide

If your acne is mostly deep, inflamed, and clustered around the jawline and chin (the classic adult hormonal pattern), topical dapsone 7.5% gel has trial data suggesting a stronger response in that subgroup [2], and it's a reasonable first choice to discuss with a prescriber. If your acne is more comedonal (blackheads, whiteheads) with moderate inflammatory lesions and you're also using benzoyl peroxide or a retinoid, clindamycin as part of a combination product is a well-established, cheaper option with a long track record, provided it's not used alone long-term [1]. If you've tried one and had an incomplete response, combination therapy under a prescriber's guidance is common and reasonable. And if you or a family member has any history suggestive of G6PD deficiency, mention it to your prescriber regardless of which topical you're using, both because it's relevant if oral options are ever considered down the line, and because it's simply good medical history to have on record. For patients managing an ongoing topical dapsone routine, understanding practical basics helps adherence: check how Dapsone Rx dosage works, review storage and shelf life guidance, and confirm whether it needs refrigeration since gel formulations can be sensitive to heat and light.

Where does Dapsone fit into getting a prescription?

If you've decided topical dapsone is worth trying based on your acne pattern, the next step is a legitimate prescription, not a guess at an over-the-counter substitute (there isn't one; dapsone gel is prescription-only in the US). Dapsone Rx operates as a provider-reviewed route to a prescription, with orders fulfilled through a licensed pharmacy partner, so you're not stuck waiting weeks for a dermatology appointment just to start a topical that has a solid safety record for on-skin use. That said, this article is meant to be useful whether or not you ever use that service. The clinical comparison above between dapsone and clindamycin holds regardless of where you get the prescription filled. What matters most is getting an accurate read on your acne pattern (inflammatory versus comedonal, hormonal versus not) so whichever drug you start with is actually matched to what's going on with your skin.

Frequently asked questions

Is dapsone or clindamycin better for acne?

Neither is universally better. Trial data suggests topical dapsone may work especially well for adult women with jawline and chin acne, while clindamycin (usually combined with benzoyl peroxide) has strong data for comedonal and moderate inflammatory acne generally. The right choice depends on your acne pattern, not a single winner.

Can I use dapsone and clindamycin at the same time?

Yes, dermatologists commonly combine them for acne that isn't fully controlled by one agent. Apply them at different times of day if you're also using benzoyl peroxide alongside dapsone, since combining dapsone and benzoyl peroxide directly can cause temporary yellow-orange skin discoloration.

Does topical dapsone require a G6PD test like oral dapsone does?

No. Topical dapsone gel (Aczone) trials did not show the hemolytic effects seen with oral dapsone and did not require G6PD screening. G6PD testing is a standard requirement specifically for oral dapsone, which is dosed systemically and carries real hemolysis risk, per FDA labeling.

Why does oral dapsone require G6PD testing?

G6PD deficiency, an inherited enzyme condition, sharply raises the risk of severe hemolytic anemia on oral dapsone. The FDA label states patients should be screened for G6PD deficiency before starting dapsone, since hemolysis is dose-related and can be dangerous in deficient patients.

Is clindamycin an antibiotic and does that mean resistance is a risk?

Yes, clindamycin is a genuine antibiotic, and using it alone long-term on skin can select for resistant C. acnes bacteria. That's why dermatology guidelines recommend pairing it with benzoyl peroxide and avoiding indefinite monotherapy.

How long until dapsone or clindamycin clears acne?

Both typically need about 12 weeks of consistent daily use before you can fairly judge effectiveness, based on the standard endpoint used in their clinical trials. Some improvement may appear by weeks 4-6, but full results take the full three months.

Is dapsone gel safe to use every day?

Yes, topical dapsone gel is designed for daily use (once or twice daily depending on the 5% or 7.5% formulation) and has a well-established safety profile in trials involving thousands of patients, with dryness and mild irritation as the most common side effects.

What's the difference between Aczone and generic dapsone gel?

Aczone is the brand name for topical dapsone gel; generic versions are now available at the same concentrations (5% or 7.5%). Generics are typically cheaper and considered equally effective by the FDA's generic approval standards.

Can men use dapsone gel for acne too?

Yes, dapsone gel is approved for anyone age 12 and older regardless of sex. The subgroup finding of stronger response in adult women comes from post-hoc trial analysis, not an FDA restriction; men can and do use it with good results too.

Does clindamycin cause the same yellow skin discoloration as dapsone with benzoyl peroxide?

No, that specific yellow-orange discoloration is unique to combining dapsone with benzoyl peroxide on skin simultaneously. Clindamycin doesn't cause this reaction, which is actually one reason some combination clindamycin/benzoyl peroxide products are formulated to be used together without issue.

Is oral dapsone ever prescribed for acne?

Not typically. Oral dapsone is used for conditions like dermatitis herpetiformis and leprosy, not standard acne, precisely because its systemic risks (hemolysis, methemoglobinemia, dapsone hypersensitivity syndrome) are hard to justify for a condition with safer topical options available.

What is dapsone hypersensitivity syndrome?

It's a rare but serious reaction to oral dapsone involving fever, rash, and potential organ involvement, typically appearing 2 to 6 weeks after starting the drug, according to FDA labeling. It is a risk specific to oral dapsone, not the topical gel used for acne.

Sources

  1. American Academy of Dermatology, Guidelines of care for acne vulgaris management: Topical antibiotics should be combined with benzoyl peroxide and not used as long-term monotherapy due to resistance risk
  2. FDA, Aczone (dapsone) 7.5% gel prescribing information: Phase 3 trial results for dapsone gel 7.5%, lesion reduction percentages at week 12
  3. PubMed, Clindamycin phosphate/benzoyl peroxide combination trial results, PMID 16766775: Clinical trial lesion reduction data for clindamycin/benzoyl peroxide combination gel
  4. FDA, oral dapsone tablets prescribing information (DailyMed record): Oral dapsone risks including hemolysis, methemoglobinemia, agranulocytosis, and dapsone hypersensitivity syndrome; G6PD screening requirement
  5. CDC, Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: G6PD deficiency prevalence and higher rates in specific populations